Author | Thomas Burmeister, MD, PhD

Articles

ALL in Adults: How Can We Do Better?

September 12, 2012

The most interesting developments in drug therapy for adult ALL are occurring in two fields: (1) molecularly targeted therapies and (2) the use of antibodies, conjugated antibodies, or antibody constructs.